Alcon AG | ALC - Current Assets


Alcon AG reported $6.62B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
AstraZeneca USD 27.97B 1.65B Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
Essilor EUR 11.24B 770M Jun/2026
Fresenius EUR 11.61B 456M Jun/2026
Fresenius Medical Care EUR 7.69B 418.66M Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.77B 393M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Philips EUR 9.33B 454M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Smith & Nephew USD 4.39B 240M Jun/2026
Sonova Holding CHF 1.91B 466.3M Jun/2025
UCB EUR 6.05B 733M Dec/2025